| Address: | Suite 1540, San Francisco, CA 94111, USA |
|---|---|
| Postal code: | 94111 |
| Phone: | (415) 981-7238 |
| Website: | http://aceabiotech.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Acea Biotech, use the form below and your opinion, advice or comment will appear in this space.
Acea Biotech is based in San Francisco, California and focused on the development of a novel, small-molecule compound called Corifungin. Patient Benefits.
Acea Biotech Sanfrancisko pasta indekss 94111-4007. Adrese: 3 Embarcadero Ctr Ste 460. Tālrunis/fakss: (415) 981-7200. 0.5 Cybo Vērtējums. Acea Biotech darbojas Mājsaimniecības preču vairumtirdzniecība, Aptiekas un aptiekas aktivitātēs.
Check out Acea Biotech's profile on Owler, the world's largest community-based business insights platform. Acea Biotech's Competitors, Revenue, Number of Employees, Funding and Acquisitions. Oops! Suite 1540. San Francisco, California94111. 415.981.7238.
The latest news, comment and analysis about Acea Biotech from the Vantage editorial team. Acea Biotech. There are no articles to show here.
Acea Biotech, Inc. is a pharmaceutical company focused on developing therapies against infectious diseases. We are an early stage small molecule drug discovery company. PSEPS.
anti - fungal, early stage biotech, new drug, biotech, Contact ACEA BIOTECH. Tweet. www.aceabiotech.com.
Acea biotech, inc. ACEA BIOTECH, INC. Patent applications. Patent application number.
ACEA BIOTECH, INC. (Delaware (US), 13 Nov 2008- ). inactive AUSTRALIAN COUNCIL FOR EDUCATIONAL ADMINISTRATION (ACEA - NSW) INCORPORATED (Australia, 23 Feb 1994-21 May 2010).
Today, the management team of Acea Biotech met with the FDA in a pre-IND meeting. John Farley, Acting Director, Division of Anti-Infective Products and his Acea Biotech is based in San Francisco, California and focused on the development of a novel, small-molecule compound called Corifungin.
Acea Biotech is based in San Francisco, California and focused on the development of a novel, small-molecule compound called Corifungin. Patient Benefits.